109685 ⎘
dsDNA viruses; Details; Adenoviridae; Mastadenovirus, e.g. human or simian adenoviruses; Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
STABILIZED TRIMERIC CLASS I FUSION PROTEINS
#2ADENOVIRUS FORMULATIONS
#3COMPOSITIONS AND METHODS FOR SELECTIVE GENE REGULATION
#4Machine Methods To Determine Neoepitope Payload Toxicity
#5METHODS AND COMPOSITIONS COMPRISING TUMOR SUPPRESSOR GENE THERAPY AND CD122/CD132 AGONISTS FOR THE TREATMENT OF CANCER
#6A CHIMERIC HELPER NUCLEIC ACID MOLECULE COMPRISING HELPER ELEMENTS FROM THREE DISTINCT HELPER VIRUSES
#7ADENOVIRAL VECTOR VACCINE AGAINST RESPIRATORY SYNCYTIAL VIRUS, AND PREPARATION METHOD THEREFOR AND USE THEREOF
#8MEANS FOR GENERATING ADENOVIRAL VECTORS FOR CLONING LARGE NUCLEIC ACIDS
#9METHOD FOR THE PURIFICATION OF RECOMBINANT ADENOVIRUS VECTORS
#10PREFUSION RSV F PROTEINS AND THEIR USE
#11ADENOVIRAL HELPER VECTORS
#12PREFUSION RSV F PROTEINS AND THEIR USE
#13Adenoviral Vectors Comprising Partial Deletions of E3
#14TUMOR-SELECTIVE E1A AND E1B MUTANTS
#15VIRAL VECTOR ASSAY AND VECTOR
#16METHODS OF TREATING SOLID OR LYMPHATIC TUMORS BY COMBINATION THERAPY
#17ADENOVIRAL CHIMERIC TDP-43 PROTEINS
#18ADENOVIRUS-BASED NUCLEIC ACIDS AND METHODS THEREOF
#19RECOMBINANT CHIMERIC ADENOVIRAL VECTOR SUBSTITUTED BY KNOB GENE OF CHIMPANZEE ADENOVIRUS SEROTYPE 6, AND APPLICATION THEREOF
#20RESCUE OF RECOMBINANT ADENOVIRUSES BY CRISPR/CAS-MEDIATED IN VIVO TERMINAL RESOLUTION
#21CTA VACCINE CASSETTES
#22CONSTRUCTION OF NOVEL HUMAN INFLUENZA VIRUS VACCINE AND APPLICATION
#23Adenoviral Vector Transduced Apheresis Product
#24MODIFIED ADENOVIRUSES
#25Anti COVID-19 Therapies targeting nucleocapsid and spike proteins
#26COMPOSITIONS AND METHODS FOR RECOMBINANT AAV PRODUCTION
#27INTEGRATIVE PLASMID
#28ADENOVIRAL VECTORS ENCODING HEPATITIS B VIRAL ANTIGENS FUSED TO HERPES VIRUS GLYCOPROTEIN D AND METHODS OF USING THE SAME
#29NOVEL CRISPR ENZYMES AND SYSTEMS
#30Adenoviral Mediated Targeting of Activated Immune Cells
#31METHODS OF CYTOTOXIC GENE THERAPY TO TREAT TUMORS
#32CpG REDUCED FACTOR VIII VARIANTS, COMPOSITIONS AND METHODS AND USES FOR TREATMENT OF HEMOSTASIS DISORDERS
#33INTEGRATIVE PLASMID
#34CELL PRODUCTION METHOD
#35A GENE THERAPY STRATEGY TO RESTORE ELECTRICAL AND CARDIAC FUNCTION, AND CARDIAC STRUCTURE, IN ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY
#36HIV VACCINES AND METHODS OF USING
#37STABILIZED FORMULATIONS OF CHIMPANZEE ADENOVIRUS
#38Viral Vaccines
#39FORMULATIONS FOR SMALL INTESTINAL DELIVERY OF RSV AND NOROVIRUS ANTIGENS
#40VIRAL VECTOR STABILIZATION
#41IMMUNOMODULATORY FUSION PROTEINS
#42Novel chimpanzee adenovirus vector, construction method therefor, and application thereof
#43THERAPEUTIC PAPILLOMA VIRUS VACCINES
#44Co-Delivery of a Gene Editor Construct and a Donor Template
#45ADENOVIRAL VECTOR SYSTEM FOR GENE DELIVERY
#46TREATMENT AND METHOD FOR INHIBITING LATE NA CURRENT
#47Multicistronic Vaccine and Methods for Producing and Using the Same
#48HIV VACCINES AND METHODS OF USING
#49FORMULATIONS FOR SMALL INTESTINAL DELIVERY
#50Adeno-Associated-Virus Rep Sequences, Vectors and Viruses
#51ADENOVIRUS ARMED WITH BISPECIFIC T CELL ACTIVATOR
#52COMPOSITIONS AND METHODS FOR INDUCING AND ENHANCING AN IMMUNE RESPONSE
#53IMMUNE CHECKPOINT INHIBITOR CO-EXPRESSION VECTORS
#54ONCOLYTIC ADENOVIRUSES FOR TREATING CANCER
#55BAG3 COMPOSITIONS AND METHODS
#56VECTOR FOR CANCER TREATMENT
#57COMPOSITIONS, KITS AND METHODS FOR TREATMENT OF COMPLEMENT-RELATED DISORDERS
#58COMPOSITIONS AND METHODS FOR INHIBITING VIRAL VECTOR-INDUCED INFLAMMATORY RESPONSES
#59HEPATITIS B IMMUNISATION REGIMEN AND COMPOSITIONS
#60IMMUNOGENIC COMPOSITIONS AND USES THEREOF
#61VIRUS
#62Adenoviral vector transduced apheresis product
#63NOVEL VACCINE FORMULATIONS FOR MYCOBACTERIUM TUBERCULOSIS AND USE OF THEREOF
#64ONCOLYTIC ADENOVIRUSES ARMED WITH HETEROLOGOUS GENES
#65Adenoviral Vector
#66ADENOVIRAL SEROTYPE 35 HELPER VECTORS
#67IMMUNOGENIC COMPOSITIONS AND USES THEREOF
#68VACCINE COMPOSITION COMPRISING ENCODED ADJUVANT
#69ADENOVIRUS FOR ANTI-TUMOUR THERAPY
#70METHODS AND COMPOSITIONS FOR PRODUCING AN ADENOVIRUS VECTOR FOR USE WITH MULTIPLE VACCINATIONS
#71NEOANTIGEN ADJUVANT AND MAINTENANCE THERAPY
#72USE OF ONCOLYTIC ADENOVIRUS FOR THE TREATMENT OF PEDIATRIC BRAIN CANCER
#73Prefusion RSV F proteins and their use
#74Stabilized Pre-Fusion PIV3 F Proteins
#75MODIFIED CHIMERIC CORONAVIRUS SPIKE PROTEIN FOR ENHANCEMENT OF VIRAL TITERS
#76Adenovirus armed with bispecific T cell activator
#77ZIKA/DENGUE VACCINE AND APPLICATION THEREOF
#78CRISPR enzymes and systems
#79Epicardial Delivery of Gene Therapy
#80METHODS FOR INDUCING AN IMMUNE RESPONSE VIA BUCCAL AND/OR SUBLINGUAL ADMINISTRATION OF A VACCINE
#81GENE THERAPY FOR RETINAL DISEASES
#82Immunogenic compositions and uses thereof
#83HOMOLOGOUS ADENOVIRAL VACCINATION
#84Simian adenoviral vectors with two expression cassettes
#85Adenoviral vectors encoding hepatitis b viral antigens fused to herpes virus glycoprotein d and methods of using the same
#86IN UTERO CRISPR-MEDIATED THERAPEUTIC EDITING OF GENES
#87SARS-CoV-2 vaccines comprising human adenovirus vectors encoding spike and nucleocapsid-ETSD immunogens
#88ADENO-ASSOCIATED VIRUS (AAV) PRODUCER CELL LINE AND RELATED METHODS
#89Prefusion RSV F proteins and their use
#90GORILLA ADENOVIRUS NUCLEIC ACID- AND AMINO ACID-SEQUENCES, VECTORS CONTAINING SAME, AND USES THEREOF
#91Mesothelioma Gene Therapy
#92COMPOSITIONS USEFUL IN TREATMENT OF ORNITHINE TRANSCARBAMYLASE (OTC) DEFICIENCY
#93Compositions and Methods for Targeting Stromal Cells for the Treatment of Cancer
#94Influenza vaccines
#95Modified adenoviruses
#96METHODS OF TREATING GLIOBLASTOMA
#97METHODS AND COMPOSITIONS FOR PRODUCING AN ADENOVIRUS VECTOR FOR USE WITH MULTIPLE VACCINATIONS
#98VACCINE COMPOSITIONS FOR MUCOSAL IMMUNE RESPONSE
#99Anti COVID-19 Therapies targeting nucleocapsid and spike proteins
#100CONJUGATE SYSTEMS AND METHODS OF USE THEREOF
#101ADENOVIRUS COMPRISING AN ALBUMIN-BINDING MOIETY
#102METHODS OF CYTOTOXIC GENE THERAPY TO TREAT TUMORS
#103CELL LINE FOR USE IN PRODUCING RECOMBINANT ADENOVIRUSES
#104METHOD FOR PREPARING ADENOVIRUS VECTOR VACCINE BY MEANS OF PERFUSION CULTURE PROCESS
#105INTEGRATION OF LARGE ADENOVIRUS PAYLOADS
#106THERAPEUTIC AGENT FOR EGFR GENE MUTATION-POSITIVE LUNG CANCER COMPRISING REIC/Dkk-3 GENE
#107Adenoviral Vectors Comprising Partial Deletions of E3
#108Tumor-selective E1a and E1b mutants
#109ENHANCED SYSTEMS FOR CELL-MEDIATED ONCOLYTIC VIRAL THERAPY
#110CORONAVIRUS VACCINE CONSTRUCTS AND METHODS OF MAKING AND USING SAME
#111COMPOSITIONS AND METHODS FOR TREATING CANCER
#112RAPID VERIFICATION OF VIRUS PARTICLE PRODUCTION FOR A PERSONALIZED VACCINE
#113CHIMERIC ADENOVIRAL VECTORS
#114MESENCHYMAL STEM CELLS THAT ENABLE TUMOR TARGETING IMPROVEMENT AND VIRUS MASS-PRODUCTION
#115MAINTAINING DNA FRAGMENTS IN EUKARYOTIC CELLS, APPROACHES AND USES
#116VIRAL VECTOR STABILIZATION
#117HELPER PLASMID-BASED GUTLESS ADENOVIRUS PRODUCTION SYSTEM
#118VIRAL DETECTION ASSAY
#119DELIVERY OF SIALIDASE TO CANCER CELLS, IMMUNE CELLS AND THE TUMOR MICROENVIRONMENT
#120ENGINEERED ONCOLYTIC ADENOVIRUS
#121Neoepitope vaccine and immune stimulant combinations and methods
#122VECTOR FOR CANCER TREATMENT
#123MIR-149-3P AND METHOD FOR TREATING METABOLIC DISEASE USING THE SAME
#124Method of inducing immunity against SARS-CoV-2 using spike (s) and nucleocapsid (N)-ETSD immunogens delivered by a replication-defective adenovirus
#125Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
#126MULTIVIRUS-SPECIFIC T CELL IMMUNOTHERAPY
#127VISMODEGIB IN COMBINATION WITH A REPLICATION-DEFICIENT TYPE 5 ADENOVIRUS FOR EXPRESSION OF INTERFERON GAMMA FOR THE TREATMENT OF SKIN CANCER
#128ADENOVIRAL VECTORS ENCODING HEPATITIS B VIRAL ANTIGENS FUSED TO HERPES VIRUS GLYCOPROTEIN D AND METHODS OF USING THE SAME
#129GENE DELIVERY SYSTEM CONTAINING RELAXIN GENE AND PHARMACEUTICAL COMPOSITION USING RELAXIN
#130LONG POLY(A) PLASMIDS AND METHODS FOR INTRODUCTION OF LONG POLY(A) SEQUENCES INTO THE PLASMID
#131Methods of treating solid or lymphatic tumors by combination therapy
#132Modified EC7 Cells Having Low Toxicity to Viral Production Payloads
#133CULTURE SYSTEMS FOR THE EFFICIENT PRODUCTION OF GENE TRANSFER VECTORS
#134SHARED NEOANTIGEN VACCINES
#135Machine Methods To Determine Neoepitope Payload Toxicity
#136TARGETING PD-L1 ON TUMOR CELLS
#137COMPOSITIONS AND METHODS COMPRISING VIRAL VECTOR SYSTEMS FOR MULTIPLEXED ACTIVATION OF ENDOGENOUS GENES AS IMMUNOTHERAPY AND VIRAL-BASED IMMUNE-GENE THERAPY
#138ADENOVIRUS COMPRISING A MODIFIED ADENOVIRUS HEXON PROTEIN
#139Formulations for small intestinal delivery of RSV and norovirus antigens
#140ADENOVIRUS VECTORS AND USES THEREOF
#141VIRUSES WITH MODIFIED CAPSID PROTEINS
#142Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
#143ENDOTHELIAL AND SMOOTH MUSCLE LIKE TISSUE PRODUCED FROM URINE CELLS AND USES RELATED THERETO
#144MAMMALIAN EXPRESSION VECTORS
#145ADENOVIRAL- BASED BIOLOGICAL DELIVERY AND EXPRESSION SYSTEM FOR USE IN THE TREATMENT OF OSTEOARTHRITIS
#146BIODEGRADABLE POLYMERIC PARTICLES ENCAPSULATING AN ACTIVE AGENT, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
#147METHODS OF CYTOTOXIC GENE THERAPY TO TREAT TUMORS
#148SINGLE PLASMID VECTOR SYSTEM FOR PACKAGING RECOMBINANT HUMAN ADENOVIRUS TYPE 4 AND APPLICATION THEREOF
#149HUMAN HEAD AND NECK CANCER TREATMENT
#150Adenoviral vector system for gene delivery
#151Helper-dependent adenoviral gene therapy delivery and expression system
#152Adenovirus polynucleotides and polypeptides
#153Adeno-associated viral chimeric TDP-43 proteins
#154COMPOSITIONS AND METHODS FOR DECREASING INTRAOCULAR PRESSURE
#155Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
#156AGENT FOR INDUCING SPECIFIC IMMUNITY AGAINST SEVERE ACUTE RESPIRATORY SYNDROME VIRUS SARS-COV-2 IN LIQUID FORM (VARIANTS)
#157RECOMBINANT AD35 VECTORS AND RELATED GENE THERAPY IMPROVEMENTS
#158Recombinantly-modified adeno-associated virus (rAAV) having improved packaging efficiency
#159METHODS FOR PRODUCING A LIBRARY OF BIOLOGICAL MOLECULES
#160GENE THERAPY FOR MESOTHELIOMA
#161PHARMACEUTICAL AGENT FOR INDUCING SPECIFIC IMMUNITY AGAINST SARS-COV-2
#162METHODS AND COMPOSITIONS COMPRISING ENHANCED TARGETED IMMUNE GENE THERAPY FOR THE TREATMENT OF CANCER
#163Adenoviral vector
#164HIV vaccines and methods of using
#165OPTIMIZED SUMF1 GENES AND EXPRESSION CASSETTES AND THEIR USE
#166Compositions And Methods For Viral Delivery Of Neoepitopes And Uses Thereof
#167GENETIC AMPLIFIED TUMOR HOMING NANOPARTICLES AND COMPOSITIONS AND METHODS THEREOF
#168Adenoviral vectors encoding hepatitis B viral antigens fused to herpes virus glycoprotein D and methods of using the same
#169Single cycle replicating adenovirus vectors
#170DELIVERY VECTORS AND PARTICLES FOR EXPRESSING CHIMERIC RECEPTORS AND METHODS OF USING THE SAME
#171ONCOLYTIC ADENOVIRAL VECTOR EXPRESSING PEPTIDYLARGININE DEIMINASE AND TISSUE INHIBITOR OF METALLOPROTEINASE
#172METHODS OF ANTI-TUMOR THERAPY
#173PV-DELETED BOVINE ADENOVIRUS
#174ONCOLYTIC ADENOVIRAL VECTOR EXPRESSING A MEMBER OF THE B7 FAMILY OF COSTIMULATORY LIGANDS AND ADA
#175COMPOSITIONS AND METHODS FOR SELECTIVE GENE REGULATION
#176Recombinant adenoviruses carrying transgenes
#177ALPHAVIRUS NEOANTIGEN VECTORS AND INTERFERON INHIBITORS
#178METHODS OF TREATING SOLID OR LYMPHATIC TUMORS BY COMBINATION THERAPY
#179COMPOSITIONS AND METHODS FOR TREATING CANCER
#180Immunogen for broad-spectrum influenza vaccine and application thereof
#181CHIMPANZEE ADENOVIRUS CONSTRUCTS WITH LYSSAVIRUS ANTIGENS
#182Methods for inducing an immune response via buccal and/or sublingual administration of a vaccine
#183Modified adenoviruses
#184Viral vector assay and vector
#185ADENOVIRAL-BASED BIOLOGICAL DELIVERY AND EXPRESSION SYSTEM FOR USE IN THE TREATMENT OF OSTEOARTHRITIS
#186Chimpanzee adenoviral vector-based filovirus vaccines
#187Prefusion RSV F proteins and their use
#188ADENOSOMES
#189HELPER-DEPENDENT ADENOVIRAL GENE THERAPY DELIVERY AND EXPRESSION SYSTEM
#190Influenza vaccines
#191Melanoma Canine Vaccine Compositions and Methods of Use Thereof
#192Self-replicating cell selective gene delivery compositions, methods, and uses thereof
#193Compositition and uses of teleost invariant chain to enhance T cell response to a vaccine
#194MODULATION OF ANTIGEN IMMUNOGENICITY BY DELETING EPITOPES RECOGNIZED BY NKT CELLS
#195ONCOLYTIC ADENOVIRUS ENCODING A B7 PROTEIN
#196Cancer therapy
#197Adeno-Associated-Virus Rep Sequences, Vectors and Viruses
#198METHODS AND COMPOSITIONS FOR TREATMENT OF INTERFERON-RESISTANT TUMORS
#199METHODS AND COMPOSITIONS FOR PRODUCING A VIRUS
#200ADENOVECTORS FOR DELIVERY OF THERAPEUTIC GENETIC MATERIAL INTO T CELLS
#201MODIFIED SEROTYPE 28 ADENOVIRAL VECTORS
#202Hepatitis B virus (HBV) vaccines and uses thereof
#203CHIMPANZEE ADENOVIRUS CONSTRUCTS WITH LYSSAVIRUS ANTIGENS
#204Oncolytic virus or antigen presenting cell mediated cancer therapy using type I interferon and CD40-ligand
#205Potent and short promoter for expression of heterologous genes
#206MULTIVIRUS-SPECIFIC T CELL IMMUNOTHERAPY
#207Simian adenovirus vectors comprising the ChAd-157 fiber protein
#208NUCLEOTIDE VACCINE
#209IL13Rα2 binding agents and use thereof
#210Immunodeficiency virus type 1 (HIV-1) mutant envelope proteins
#211IMMUNE CHECKPOINT INHIBITOR CO-EXPRESSION VECTORS
#212Potent and balanced bidirectional promoter
#213Adenovirus and uses thereof
#214Multimodal Vector for Dendritic Cell Infection
#215SHARED ANTIGENS
#216Adenoviral vectors with two expression cassettes encoding RSV antigenic proteins or fragments thereof
#217Replication competent adenoviral vectors
#218Enhanced promoter
#219Nucleic acids encoding Zika virus-like particles and their use in Zika virus vaccines and diagnostic assays
#220Oncolytic adenoviruses armed with heterologous genes
#221Tumor-selective E1A and E1B mutants
#222Hepatitis B immunization regimen and compositions
#223Immunomodulatory fusion proteins
#224NOVEL APPLICATION OF HEPARIN-BINDING EPIDERMAL GROWTH FACTOR-LIKE GROWTH FACTOR FOR MEDICAL PURPOSES
#225Non human great apes adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof
#226VACCINE COMPOSITION
#227METHOD OF PROVIDING SAFE ADMINISTRATION OF ADENOVIRAL VECTORS ENCODING A ZIKA VIRUS ANTIGEN
#228Mosaic chimeric viral vaccine particle
#229METHODS AND COMPOSITIONS COMPRISING TUMOR SUPPRESSOR GENE THERAPY AND CD122/CD132 AGONISTS FOR THE TREATMENT OF CANCER
#230Recombinant adenoviruses and stem cells comprising same
#231MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) COMPOSITIONS AND METHODS OF USE THEREOF
#232Compositions and methods to modulate cell activity
#233Rapid verification of virus particle production for a personalized vaccine
#234Simian (gorilla) adenovirus or adenoviral vectors and methods of use
#235Adenoviral vectors comprising partial deletions of E3
#236Antiviral vaccines with improved cellular immunogenicity
#237Stable, spray dried, immunogenic, viral compositions
#238TROPISM MODIFIED CANCER TERMINATOR VIRUS (AD.5/3 CTV;AD.5/3-CTV-M7)
#239Compositions useful in treatment of ornithine transcarbamylase (OTC) deficiency
#240Expression systems
#241Modified EC7 cells having low toxicity to viral production payloads
#242Immunogenic compositions and uses thereof
#243Viral vector stabilization
#244Viral vector stabilization
#245Adenovirus vectors and uses thereof
#246Multivalent Antigens Stimulating TH1 and TH2
#247Adenovirus and uses thereof
#248Oncolytic virotherapy with helper-dependent adenoviral-based vectors expressing immunomodulatory molecules
#249Eukaryotic cell line
#250SIMIAN ADENOVIRAL VECTORS WITH TWO EXPRESSION CASSETTES
#251Methods of transdifferentiation and methods of use thereof
#252Compositions and methods for viral delivery of neoepitopes and uses thereof
#253NOVEL CRISPR ENZYMES AND SYSTEMS
#254Isolated recombinant oncolytic adenoviruses, pharmaceutical compositions, and uses thereof for drugs for treatment of tumors and/or cancers
#255Compositions and methods for inhibiting viral vector-induced inflammatory responses
#256Cancer-specific trans-splicing ribozymes and use thereof
#257Simian adenoviruses SAdV-43, -45, -46, -47, -48, -49, and -50, and uses thereof
#258Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
#259Single cycle replicating adenovirus vectors
#260Adenoviral vectors
#261VECTORS CONDITIONALLY EXPRESSING THERAPEUTIC PROTEINS, HOST CELLS COMPRISING THE VECTORS, AND USES THEREOF
#262Life-cycle-defective adenovirus helper viruses, their production and use for producing rAAV
#263METHODS FOR INDUCING AN IMMUNE RESPONSE VIA BUCCAL AND/OR SUBLINGUAL ADMINISTRATION OF A VACCINE
#264Adenovirus armed with bispecific T cell activator
#265Gene therapy strategy to restore electrical and cardiac function, and cardiac structure, in arrhythmogenic right ventricular cardiomyopathy
#266Adeno-associated virus (AAV) producer cell line and related methods
#267COMPOSITIONS, KITS AND METHODS FOR TREATMENT OF COMPLEMENT-RELATED DISORDERS
#268aNK AND IL-12 COMPOSITIONS AND METHODS
#269Adenovirus comprising an albumin-binding moiety
#270Chikungunya virus antigen constructs
#271MATERIALS AND METHODS FOR INCREASING IMMUNE RESPONSES
#272Compositions and methods for flavivirus vaccination
#273Mesothelioma Gene Therapy
#274Viral Vector
#275Therapeutic compositions and methods of use for treating cancer
#276Compositions and methods for tumor vaccination and immunotherapy involving HER antigens
#277Compositions of CRACC fusions and methods for modulating an immune response against cancers, infections diseases and disorders
#278Adenovirus polynucleotides and polypeptides
#279Enhanced systems for cell-mediated oncolytic viral therapy
#280Oncolytic virus and method
#281Viral vector stabilization
#282Compositions and methods of treatment
#283Viral vector production system
#284Recombinant simian adenoviral vectors encoding a heterologous fiber protein and uses thereof
#285Use of adenovirus and nucleic acids coding therefor
#286Compositions and methods for targeting stromal cells for the treatment of cancer
#287Mosaic chimeric viral vaccine particle
#288Multiple transgene recombinant adenovirus
#289ANIMAL MODEL OF A MOOD DISORDER AND SCREENING METHOD
#290Immunomodulatory compositions and methods of use thereof
#291Methods of inducing responsiveness to anti-angiogenic agent
#292Vaccine directed to induction of immune response to protein and glycolipid antigens of bacterial cells through interaction of CD40L/CD40 receptor axis with complex of glycolipid/CD1d receptor in NKT cells and in dendritic cells
#293Immunization agents and methods of use
#294MEANS FOR GENERATING ADENOVIRAL VECTORS FOR CLONING LARGE NUCLEIC ACIDS
#295Neoepitope vaccine and immune stimulant combinations and methods
#296Single cycle replicating adenovirus vectors
#297METHODS OF USE OF INHIBITORS OF PHOSPHODIESTERASES AND MODULATORS OF NITRIC OXIDE, REACTIVE OXYGEN SPECIES, AND METALLOPROTEINASES IN THE TREATMENT OF PEYRONIE'S DISEASE, ARTERIOSCLEROSIS AND OTHER FIBROTIC DISEASES
#298ADENOVIRAL-BASED BIOLOGICAL DELIVERY AND EXPRESSION SYSTEM FOR USE IN THE TREATMENT OF OSTEOARTHRITIS
#299Methods and Compositions for Treatment of Interferon-Resistant Tumors
#300Method of treating type I diabetes using an AAV vector encoding uracortin 2